"Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region Living With a Myeloma in West-Occitanie"

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
Multiple Myeloma
Interventions
OTHER

quality of life questionnaires (EORTC QLQ-C30 ; EORTC QLQMY20 ; EQ-5D-5L ; Cohen's stress scale)

"Excepted the delivery of quality of life questionnaires (a maximum of 5 times during the course of treatment) specific to this study, only the data available during the course of patient care will be collected.~The quality of life questionnaires and the perceived stress questionnaire will be given to patients :~* At diagnosis (before starting 1st line of treatment),~* after the induction phase (before autologous transplantation for patients who will be transplanted),~* after the consolidation phase,~* after the maintenance phase : 1 year and 2 years after the start of the maintenance."

Trial Locations (1)

31059

RECRUITING

IUCT-Oncopole - Toulouse University Hospital, Toulouse

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Takeda

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

University Hospital, Toulouse

OTHER